Filing Details

Accession Number:
0001209191-13-007372
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-08 16:19:51
Reporting Period:
2013-02-06
Filing Date:
2013-02-08
Accepted Time:
2013-02-08 16:19:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
78003 Pfizer Inc 235 East 42Nd Street
New York NY 10017
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2013-02-06 12,915,000 $0.00 12,915,000 No 4 C Direct
Class A Common Stock Disposition 2013-02-06 99,015,000 $0.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2013-02-06 12,915,000 $0.00 12,915,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
400,985,000 No 4 C Direct
Footnotes
  1. The Class A Common Stock was acquired pursuant to the conversion of Class B Common Stock in an exempt transaction under the Exchange Act Rule 16b-6(b). The Class B Common Stock was converted into Class A Common Stock on a one-for-one basis and had no exercise or conversion price.
  2. Pfizer Inc. may be deemed a director of the Issuer on the basis of its relationship with five of the directors of the Issuer.
  3. Pfizer Inc. disposed of 99,015,000 shares of Class A Common Stock in exchange for outstanding debt obligations of Pfizer Inc. The debt obligations were valued at their fair market value, and the fair market value of the debt obligations exchanged equaled $25.038 per share of Class A Common Stock exchanged.
  4. Each share of Class B Common Stock held by Pfizer Inc. or one of its subsidiaries will be convertible into one share of Class A Common Stock at any time but will not be convertible if held by any other holder.